Global RNAi Therapeutics Market Report 2023-2030, with Competitor Analysis for Alnylam Pharmaceuticals, QIAGEN, Olix Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals & Benitec Biopharma

DUBLIN, Jan. 18, 2024 /PRNewswire/ — The “RNAi Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030” report has been added to ResearchAndMarkets.com’s offering. The global RNAi therapeutics market was valued at USD 11.20 billion in 2022 and is…